International Clinical Trial: A nationwide multi-institutional retrospective study to examine predictors of early postoperative recurrence in anatomically resectable pancreatic cancer treated with neoadjuvant chemotherapy (NAC-GS) (NAC-PIONEER trial)

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000058482) titled 'A nationwide multi-institutional retrospective study to examine predictors of early postoperative recurrence in anatomically resectable pancreatic cancer treated with neoadjuvant chemotherapy (NAC-GS) (NAC-PIONEER trial)' on Aug. 1.

Study Type: Observational

Study Design: Not selected Not selected

Primary Sponsor: University of Toyama

Condition: Resectable pancreatic cancer

Recruitment Status: Not Recruiting

Phase: Not selected

Date of First Enrollment: 2025/08/01

Target Sample Size: 5500

Countries of Recruitment: Japan

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cg...